Faridoxorubicin
Product Specifications
CAS Number
1841402-73-0
Target
Others
Related Pathways
Others
Bioactivity
Faridoxorubicin (AVA-6000) is a prodrug that targets fibroblast activation protein alpha (FAPα) . It releases active doxorubicin through FAPα-mediated cleavage, enhancing drug exposure within tumors while reducing cardiac toxicity. Faridoxorubicin holds potential for research in solid tumors, such as liver metastases from colorectal cancer.
Smiles
OC=1C2=C([C@@H](O[C@H]3C[C@H](NC(=O)[C@H]4N(C([C@H](NC(=O)C=5C=CN=CC5)C)=O)CCC4)[C@H](O)[C@H](C)O3)C[C@@](C(CO)=O)(O)C2)C(O)=C6C1C(=O)C=7C(C6=O)=C(OC)C=CC7
Molecular Formula
C41H44N4O14
Molecular Weight
816.81
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680496-500 1x 500 µL
SUMO-2/3 (SM23/496), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472307-100 1x 100 µL
Moesin (rMSN/492), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB3640-100 1x 100 µL
Involucrin (Squamous Cell Terminal Differentiation Marker) (rIVRN/827), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 